Page last updated: 2024-10-27

foscarnet and Leukemia

foscarnet has been researched along with Leukemia in 4 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"Intravenous foscarnet was given on an emergency basis to 30 immunosuppressed patients with cytomegalovirus (CMV) disease, of whom 28 were organ transplant recipients."9.06Sensitivity of cytomegalovirus to intravenous foscarnet treatment. ( Akesson-Johansson, A; Lernestedt, JO; Lönnqvist, B; Ringdén, O; Wahren, B, 1986)
"Intravenous foscarnet was given on an emergency basis to 30 immunosuppressed patients with cytomegalovirus (CMV) disease, of whom 28 were organ transplant recipients."5.06Sensitivity of cytomegalovirus to intravenous foscarnet treatment. ( Akesson-Johansson, A; Lernestedt, JO; Lönnqvist, B; Ringdén, O; Wahren, B, 1986)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angarone, M1
Ison, MG1
Bacigalupo, A1
van Lint, MT1
Tedone, E1
Moro, F1
Sanna, MA1
Longren, M1
Trespi, G1
Frassoni, F1
Occhini, D1
Gualandi, F1
Peggs, KS1
Preiser, W1
Kottaridis, PD1
McKeag, N1
Brink, NS1
Tedder, RS1
Goldstone, AH1
Linch, DC1
Mackinnon, S1
Akesson-Johansson, A1
Lernestedt, JO1
Ringdén, O1
Lönnqvist, B1
Wahren, B1

Reviews

1 review available for foscarnet and Leukemia

ArticleYear
Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Zoster;

2008

Trials

2 trials available for foscarnet and Leukemia

ArticleYear
Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
    Bone marrow transplantation, 1994, Volume: 13, Issue:6

    Topics: Adult; Anemia, Aplastic; Antigens, Viral; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovi

1994
Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
    Bone marrow transplantation, 1986, Volume: 1, Issue:2

    Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female;

1986

Other Studies

1 other study available for foscarnet and Leukemia

ArticleYear
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    British journal of haematology, 2000, Volume: 111, Issue:3

    Topics: Acyclovir; Adolescent; Adult; Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cycl

2000